About this trial
The MRI perfusion imaging using arterial spin labeling (ASL)'s non-invasive technique (i.e. without injection of contrast medium) allows, thanks to recent technological improvement of the spatial resolution, measuring several perfusion parameter of the retinal tissue such as the regional Blood Flow (rBF) or the cerebral blood flow (cBF) expressed in ml/100g/min. Reliable application of ASL thus requires the precision and specificity of the MRI protocol to be tested.
Eligibility criteria
Qualifiers
Carrier of target pathologies: TAO optic neuropathy, inflammatory optic neuropathy, ischemic optic neuropathy.
no cardiovascular risk factors or other ophthalmological pathology
adhere to the study protocol after reading the patient information document
signe the informed consent form to participate in the study
Disqualifiers
Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…)
Severe claustrophobia
Trial design
Treatments tested in this trial
- MRI perfusion imaging using ASL's non-invasive technique